Revolution Medicines, Inc. Change in Other Assets increased by 6699.4% to $10.47M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 1468.8%, from -$765.00K to $10.47M. Over 4 years (FY 2021 to FY 2025), Change in Other Assets shows an upward trend with a 255.1% CAGR.
Large swings are usually related to the timing of prepayments for services or long-term supply agreements.
This captures the net change in miscellaneous operating assets not classified as receivables or inventory, such as prepa...
This is typically a smaller component of cash flow for most large-cap technology firms unless they are securing long-term supply capacity.
change_in_other_assets| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $0.00 | -$81.00K | $114.00K | -$71.00K | $153.00K | $2.05M | -$90.00K | -$88.00K | $8.67M | -$9.37M | -$125.00K | $4.13M | -$3.20M | -$2.49M | -$765.00K | $17.27M | -$3.79M | $154.00K | $10.47M |
| QoQ Change | — | — | — | +240.7% | -162.3% | +315.5% | >999% | -104.4% | +2.2% | >999% | -208.0% | +98.7% | >999% | -177.5% | +22.0% | +69.3% | >999% | -121.9% | +104.1% | >999% |
| YoY Change | — | — | — | — | — | — | >999% | -178.9% | -23.9% | >999% | -556.6% | -38.9% | >999% | -136.9% | +73.4% | -512.0% | +318.5% | -18.5% | +106.2% | >999% |